Stockreport

Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF Blood-based assay uses personalized tumor-informed approach designed to detect cancer recurrence early with an ultra-sensitive approach FREMONT, Calif.--(BUSINESS WIR [Read more]